Non-Interventional Observational Study on Patient Satisfaction With the Benepali Pre-Filled Pen
Phase of Trial: Phase IV
Latest Information Update: 30 Oct 2018
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis; Psoriatic arthritis; Rheumatoid arthritis; Spondylarthritis
- Focus Therapeutic Use
- Sponsors Biogen
- 22 Oct 2018 Status changed from recruiting to completed.
- 16 Jun 2018 Interim analysis results (as of Nov 2017, n=142) assessing patient satisfaction with Etanercept biosimilar (Sb4) pre-filled pen among rheumatoid arthritis and spondyloarthropathy patients, presented at the 19th Annual Congress of the European League Against Rheumatism.
- 19 Dec 2017 Planned End Date changed from 31 Dec 2017 to 31 Aug 2018.